Navigation Links
Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center
Date:2/11/2008

ATLANTA, and OMAHA, Neb., Feb. 11 /PRNewswire/ -- Elekta Neuromag(R), the world-leading equipment for non-invasive measurement of brain activity using Magnetoencephalography (MEG) technology, has been ordered by The Nebraska Medical Center in Omaha.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOGO )

With a reputation for excellence, innovation and extraordinary patient care, The Nebraska Medical Center has earned J.D. Power and Associates' Hospital of Distinction award for three consecutive years.

As the teaching hospital for the University of Nebraska Medical Center, this 689 licensed bed academic medical center has an international reputation for providing solid organ and bone marrow transplantation services and is well known nationally and regionally for its oncology, neurology and cardiology programs. With a history dating back to 1869, dedication to compassionate, quality patient care is the cornerstone of The Nebraska Medical Center. The not-for-profit hospital is known for excellence and innovation in medicine.

The Nebraska Medical Center is Nebraska's largest health care facility - with more than 4,900 employees and more than 1,000 physicians on staff. Its physicians practice in all major specialties and sub-specialties attracting patients from across the region and from around the world.

The Nebraska Medical Center will receive its new Elekta Neuromag MEG system in the spring/summer of 2008. With the MEG system from Elekta installed, neurosurgeons, neurologists and those in related fields will be able to non-invasively record human brain activity in real time, better and more accurately than ever before.

MEG technology is regarded as the most efficient method for tracking brain activity at millisecond resolution. Compared to EEG technology, MEG has uniquely accurate localization capabilities. Other technologies,
'/>"/>

SOURCE Elekta, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
2. Elekta Announces First Two Clinical Sites Using VMAT Cancer Treatment Capability
3. Elekta Announces Clinical Start-up of Elekta Synergy(R) S at UPMC
4. Elekta Negotiates To Acquire CMS
5. Elekta Showcases Stereotactic Systems for Cancer Care at Astro 2007
6. Beaumont Hospital, Royal Oak Treats Its First Patients With Elekta Axesse
7. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
8. Elekta Announces New Cancer Care Solutions and Highlights Personalized Efficiency at ASTRO 2007
9. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
10. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
11. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 /PRNewswire/ ... study of mazindol in children with attention deficit/hyperactivity disorder ... December 2014 . The paper, titled ... attention deficit/hyperactivity disorder" ( Konofal et al, ... eCollection 2014 ) shows that mazindol might be ...
(Date:12/22/2014)... HILL, N.C. , Dec. 22, 2014 /PRNewswire/ ... today announced that it has signed a letter ... company that has developed and patented a nanotechnology-based ... medical diagnostics products that enable rapid on-site collection ... alcohol use/abuse and health issues in an immediate, ...
(Date:12/22/2014)... ITRA Global, one of the largest organizations dedicated ... has further expanded its global reach with the affiliation ... Australia, reports Mylinda Vick, CCIM, Chairman of the ITRA ... ACORPP (Australian Corporate Property and Projects) , is a ... to a wide range of clients in the private ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 BioPlus ... specialty pharmacies, announces the promotion of Nick Maroulis, Pharm.D. ... Specialty Pharmacy Services. , In this position, Dr. ... while also managing the directors of our multi-site pharmacies ... BioPlus since 1997 and during that time he has ...
Breaking Biology Technology:Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3ALNE Announces Intention To Acquire BioTechPharma 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... FL (May 4, 2009): Uveitis, or inflammation within ... for years of visual loss roughly comparable to ... pioneering international Phase 3 program in uveitis, the ... ability of LX211 (LUVENIQ, voclosporin oral capsule) to ...
... Changes Will Result in a 35% Sales Force Reduction ... DIEGO, May 4 Amylin Pharmaceuticals, Inc. (Nasdaq: ... sales within the diabetes market. Amylin,s existing primary care ... organization that brings a specialty approach to endocrinologists and ...
... Diagnostics, LLC. (MSD) confirmed today that its investigational influenza ... of infection with the 2009 A(H1N1) swine flu. ... being developed under a contract with the Centers for ... referred to in the CDC,s Morbidity and Mortality Weekly ...
Cached Biology Technology:First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 2First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 3First oral uveitis drug reduces both inflammation and recurrence in potentially blinding eye disease 4Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market 2Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market 3Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market 4Meso Scale Diagnostics' Point of Care Influenza Test Led to the First Identification of A(H1N1) Swine Flu Infection 2
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Texas AgriLife Research program at Vernon could become a ... Malinowski, Texas AgriLife Research plant physiologist and forage agronomist ... early start about six years ago as a hobby ... Pinchak, AgriLife Research animal nutritionist, and Steve Brown, Texas ...
... "Paper of the Week" by Wai Mun Huang and ... the University of Minnesota reveals new insights into the molecular ... the pathogen responsible for crown gall disease, a tumor-forming infection ... The bacterium is parasitic: It infects its plant ...
... at the Northeast Fisheries Science Center,s Narragansett Laboratory, ... primary productivity and dissolved oxygen would lead. Now ... heads a long-term Ship of Opportunity Program (SOOP) ... platforms during their routine operations. Using an instrument, ...
Cached Biology News:Researchers take hibiscus efforts to commercialization 2Researchers take hibiscus efforts to commercialization 3NOAA plankton surveys, second longest in the North Atlantic, add to new global effort 2NOAA plankton surveys, second longest in the North Atlantic, add to new global effort 3
... monoclonal antibody which can immunocapture up to ... mitochondria. Also included are 2 mg of ... Complex V immunocapture kit allows isolation of ... small amounts of tissue. This facilitates subsequent ...
11-keto Testosterone EIA Antiserum hormones steroids antisera antiserum eias enzyme immunoassays reagents 11-keto-testosterone...
... Rabbit polyclonal to MKK6 (phospho S207) ... applications). Antigen: ... around the phosphorylation site of Serine ... Entrez Gene ID: 5608 ...
Anti-human L-Ficolin, Clone GN4, Monoclonal Antibody...
Biology Products: